Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2005-02-08
2005-02-08
Scheiner, Laurie (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S204100, C424S278100, C435S320100, C536S023720
Reexamination Certificate
active
06852324
ABSTRACT:
Ebola virus vaccines comprising nucleic acid molecules encoding Ebola viral proteins are provided. In one embodiment, the nucleic acid molecule encodes the transmembrane form of the viral glycoprotein (GP). In another embodiment, the nucleic acid molecule encodes the secreted form of the viral glycoprotein (sGP). In yet another embodiment, the nucleic acid molecule encodes the viral nucleoprotein (NP). Methods for immunizing a subject against disease caused by infection with Ebola virus are also provided.
REFERENCES:
patent: 6197568 (2001-03-01), Marks et al.
International Preliminary Examination Report from PCT/US98/27364, filed Dec. 23, 1998.
Palese et al. (1996) Negative-strand RNA viruses: Genetic engineering and applications. PNAS 93:11354-11358.
Sanchez et al. (1996) The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. PNAS 93:3602-3607.
Arai, H., et al., (1997)Inhibition of the alloantibody response by DC95 ligand. Nature Med. 3:843-848.
Border, W.A., et al., (1995)Targeting TGF-β for treatment of disease. Nature Med. 1:1000-1001.
Bowen, E.T.W., et al. (1977)Viral heamorrhagic fever in southern Sudan and northern Zaire. Lancet 1:571-573.
Bukreyev, A. A., et al. (1993)The GP-protein of Marburg virus contains the region similar to the immunosuppressive domain' of oncogenic retrovirus P15E proteins.FEBS. Lett. 323:183-187.
Cianciolo, G.J., et al. (1985)Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:453-455.
Clegg, J.C.S., et al. (1997)Vaccines against arenaviruses and filoviruses.New Generation Vaccines. (eds Levine, M.M., et al.) 749-765 (Marcel Dekker, New York).
Corr, M., et al., (1996)Gene Vaccination with Naked Plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184:1555-1560.
Davis, L.S., et al. (1995)Measurement of human and murine interleukin 2 and interleukin 4. Current Protocols in Immunology (eds. Collgan, J.E., et al. ) 6.3.1-6.3.12 (John Wiley & Sons, NY).
Doe, B., et al. (1996)Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl., Acad. Sci. USA 93:8578-8583.
Doolan, D.L., et al. (1996)Circumventing genetic restriction of protection against malaria with multigene DNA immunication: CD8 T Cell-, Interferon γ, and Nitric Oxide-Dependent immunity. J. Exp. Med. 183:1739-1746.
Harris, D.T., et al. (1987)Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J. Immunol. 138:889-894. Iwasaki, A., et al. (1997)The dominant role of bone marrow-derived cells in CTL Induction following plasmid DNA immunization at different sites. J. Immunol. 159:11-14.
Iwasaki, A., et al. (1997)The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.J. Immunol. 159:11-14.
Jahrling, P.B., et al. (1986)Passive Immunization of Ebola virus-infected cynomologus monkeys with immunoglobulin from hyperimune horses. Arch. Virol. Suppl. 11:135-140.
Jorgensen, J.L., et al. (1992)Molecular components of T-cell recognition.Annu. Rev. Immunol. 10:835-873.
Ksiazek T.G., et al. (1991)Laboratory diagnosis of Biovirus infections in nonhuman primates.Lab. Animal 20:334-46.
Ksiazek T.G., et al. (1992)Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbiol. 30:947-950.
Manthrope, M., et al. (1993)Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice.Hum. Gene. Ther. 4:419-431.
McCormick; J.B., et al. (1983)Biologic differences between strains of Ebois virus from Zaire and Sudan.J. Infect. Dis. 147:264-267.
Monaco, J.J. (1992)A molecular model of MHC class-restricted antigen processing.Immunol. Today 13:173-179.
Ohno, T., et al. (1997)Combination gene transfer to potentiate tumor regression.Gene Thera 4:361-368.
Peters, C.J., et al. (1994)Fiolviruses as emerging pathogens. Semin. Virol. 5:147-154.
Peters, C.J., et al. (1996)Filovridae: Marburg and Ebola Viruses.Fields Virology (eds. Fields, B.N., et al.) 1161-1176, Lippincott-Raven, Philadelphia.
Raz, E., et al. (1993)Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90:4523-4527.
Raz, E., et al. (1994)Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular Immunity to viruses. Proc. Natl., Acad. Sci. USA, 91:9519-9523.
Sanchez, A., et al. (1989)The Nucleoprotein gene of Ebola virus: Cloning, sequencing, and in Vitro expression.Virology 170:81-91.
Sanchez, A., et al., (1993)Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus. Res. 29:215-240.
Sanchez, A., et al. (1996)The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.Proc. Natl. Acad. Sci. USA, 93:3602-3607.
Sedegah, M., et al. (1994)Protection against malaria by immunization with plasmid DNA encoding cirumsporozoite protein. Proc. Natl. Acad. Sci, USA 91:9866-9870.Ksiazek, T.G. (1991)Laboratory diagnosis of filovirus infections in nonhuman primates. Lab. Animal 20:34-46.
Tan, B.T.G., et al. (1985)Production of monoclonal antibodies defining guinea pig T-cell surface markers and a strain 13 la-like antigen: The value of immunohistological screening. Hybridoma 4:115-124.
Tang, D.C., et al. (1992) Genetic immunization is a single method for eliciting an immune response. Nature 356:152-154.
Tascon, R.E., et al. (1996)Vaccination against tuberculosis by DNA injection.Nature Med. 2:888-892.
Ulmer, J.B., et al. (1993)Heterologous protection against influenza by injection of DNA encoding a viral protein.Science 259:1745-1749.
Volchkov, V.E., et al. (1992)The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domian similar to oncogenic retroviruses.FEBS, Lett. 305:181-184.
Waisman, A., et al. (1996)Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity.Nature Med., 2:899-905.
Wolff, J.A., et al. (1990)Direct gene transfer into mouse muscle in vivo.Science 247:1465-1468.
Xu, L., et al. (1998) Immunization for Ebola virus infection. Nature Med. 4:37-42.
Zinkemagel, R.M., et al. (1997)The discovery of MHC restriction. Immunol. Today 18:14-17.
Nabel Gary J.
Sanchez Anthony
Knobbe Martens Olson & Bear LLP
Scheiner Laurie
The United States of America as represented by the Department of
LandOfFree
Immunization for ebola virus infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunization for ebola virus infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunization for ebola virus infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3477775